More Americans will only have to pay $35 a month for insulin in 2024
Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the list prices for their insulin products.
New weight loss drugs carry high price tags and lots of questions for seniors
The medications reduce feelings of hunger, generate a sensation of fullness, and have been shown to help people lose an average of 15% or more of their weight.
RSV vaccines would greatly reduce illness if implemented like flu shots, research suggests
Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a recent study has found.
Mounjaro beats Ozempic for weight loss in early trial
The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.
Weight loss through slimming found to significantly alter microbiome and brain activity
By the end of the study, their body weight had decreased by an average of 7.6kg, or 7.8%. As expected, they had undergone reductions in body fat and waist circumference.